These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1561478)

  • 21. [Cisapride does not modify prolonged Q-T interval in patients with liver cirrhosis].
    Quera R; Madrid AM; Ugalde H; Defilippi C
    Rev Med Chil; 2000 Aug; 128(8):847-52. PubMed ID: 11129545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
    Ophoff N; Toker Y
    Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias].
    Viramontes-Madrid JL; Jerjes-Sánchez C; Pelaez-Ballestas I; Aguilar-Chiu A; Hernández-Garduño AG
    Rev Invest Clin; 2002; 54(3):192-7. PubMed ID: 12183887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical investigation of Q-T prolongation in hepatic cirrhosis].
    Li L; Liu HR; Shu JL; Xi XP; Wang Y
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2717-8. PubMed ID: 18167253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Severe ventricular arrhythmia secondary to indapamide-induced hypopotassemia].
    Guzzini F; Baroffio R; Coppetti D; Gasparini P
    Clin Ter; 1990 Nov; 135(4):283-7. PubMed ID: 1705875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Malignant ventricular hyperkinetic arrhythmias: diagnostic aspects].
    Tavazzi L
    G Ital Cardiol; 1983; 13(4):243-52. PubMed ID: 6884668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Delayed-action disopyramide in the treatment of hyperkinetic ventricular arrhythmia. A randomized clinical comparative study vs immediate-action disopyramide].
    Romanò M; Spinelli A; Cazzani E; Muzio L
    Clin Ter; 1991 Jul; 138(1):13-9. PubMed ID: 1834395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The proarrhythmogenic activity of non-anti-arrhythmia drugs. Is treatment with antihistamines and cisapride safe?].
    Pelov R; Tankova L; Krushkov I
    Vutr Boles; 1999; 31(2-3):5-9. PubMed ID: 10847134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Secondary prolongation of the QT interval and ventricular arrhythmias. Causes and treatment].
    Nielsen H
    Ugeskr Laeger; 1986 Nov; 148(48):3215-8. PubMed ID: 3810917
    [No Abstract]   [Full Text] [Related]  

  • 30. QT lengthening and arrhythmias associated with fexofenadine.
    Giraud T
    Lancet; 1999 Jun; 353(9169):2072-3. PubMed ID: 10376646
    [No Abstract]   [Full Text] [Related]  

  • 31. Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions.
    Crumb WJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):261-4. PubMed ID: 10604956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?
    Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES
    Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-arrhythmic agents in ischemic heart disease: supraventricular arrhythmias, digitalis toxicity and chronic stable ventricular ectopic beats.
    Opie LH
    Methods Find Exp Clin Pharmacol; 1982; 4(1):25-35. PubMed ID: 7087606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug interactions associated with terfenadine and related nonsedating antihistamines.
    Zechnich AD; Haxby DG
    West J Med; 1996 Jan; 164(1):68-9. PubMed ID: 8779212
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by myocardial ischemia and programmed electrical stimulation.
    Billman GE; Hamlin RL
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1517-26. PubMed ID: 8667218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ventricular arrhythmias in the acute phase of myocardial infarct and in the postinfarct. A 1-year follow-up].
    De Rosa F; Boncompagni F; Calvelli A; Paci A; Guzzo D; Fascetti F; Meringolo G; Venneri N; Plastina F
    G Ital Cardiol; 1990 Jul; 20(7):607-14. PubMed ID: 2245898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventricular arrhythmias in the elderly: prevalence, mechanisms, and therapeutic implications.
    Fleg JL
    Geriatrics; 1988 Dec; 43(12):23-9. PubMed ID: 3056779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
    Shaikh WA
    J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the anti-arrhythmic action of propafenone treatment and its influence on left ventricular function].
    Saitta A; Bonaiuto M; Mileto A; Oriti S; Cinquegrani M; Giordano G; Fodale P; Saitta M; Squadrito F
    Clin Ter; 1993 Apr; 142(4):351-60. PubMed ID: 8330479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.